These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16470176)

  • 1. FK506 controls CD40L-induced systemic autoimmunity in mice.
    Loser K; Balkow S; Higuchi T; Apelt J; Kuhn A; Luger TA; Beissert S
    J Invest Dermatol; 2006 Jun; 126(6):1307-15. PubMed ID: 16470176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity.
    Loser K; Hansen W; Apelt J; Balkow S; Buer J; Beissert S
    Gene Ther; 2005 Sep; 12(17):1294-304. PubMed ID: 15973443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity.
    Mehling A; Loser K; Varga G; Metze D; Luger TA; Schwarz T; Grabbe S; Beissert S
    J Exp Med; 2001 Sep; 194(5):615-28. PubMed ID: 11535630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity.
    Peng SL; McNiff JM; Madaio MP; Ma J; Owen MJ; Flavell RA; Hayday AC; Craft J
    J Immunol; 1997 Mar; 158(5):2464-70. PubMed ID: 9036998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation.
    Brenner MJ; Mackinnon SE; Rickman SR; Jaramillo A; Tung TH; Hunter DA; Mohanakumar T
    Restor Neurol Neurosci; 2005; 23(3-4):237-49. PubMed ID: 16082080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The skin as a site of initiation of systemic autoimmune disease: new opportunities for treatment.
    Dutz JP
    J Invest Dermatol; 2006 Jun; 126(6):1209-12. PubMed ID: 16702968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
    Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
    J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity.
    Delaney CP; Murase N; Chen-Woan M; Fung JJ; Starzl TE; Demetris AJ
    J Clin Invest; 1996 Jan; 97(1):217-25. PubMed ID: 8550837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
    Pau E; Chang NH; Loh C; Lajoie G; Wither JE
    Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
    Chen L; Overbergh L; Mathieu C; Chan LS
    Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza-induced, helper-independent CD8+ T cell responses use CD40 costimulation at the late phase of the primary response.
    Seah SG; Brady JL; Carrington EM; Ng WC; Sutherland RM; Hancock MS; La Gruta NL; Brown LE; Turner SJ; Lew AM; Zhan Y
    J Leukoc Biol; 2013 Jan; 93(1):145-54. PubMed ID: 23108101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.
    Toubi E; Shoenfeld Y
    Autoimmunity; 2004; 37(6-7):457-64. PubMed ID: 15621572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
    J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived cells are responsible for the development of autoimmune arthritis in human T cell leukemia virus type I-transgenic mice and those of normal mice can suppress the disease.
    Saijo S; Kotani M; Habu K; Ishitsuka C; Yamamoto H; Sekiguchi T; Iwakura Y
    J Immunol; 1999 Nov; 163(10):5700-7. PubMed ID: 10553101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector.
    Kimura T; Ohashi T; Kikuchi T; Kiyota H; Eto Y; Ohishi Y
    Cancer Gene Ther; 2003 Nov; 10(11):833-9. PubMed ID: 14605669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
    Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function.
    Kalled SL; Cutler AH; Datta SK; Thomas DW
    J Immunol; 1998 Mar; 160(5):2158-65. PubMed ID: 9498753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.